Cohort profile: The Swedish women’s lifestyle and health cohort

International Journal of Epidemiology

Volumn 46, Issue 2, 2017, Pages

  Roswall, Nina ^a,b   Sandin, Sven ^b   Adami, Hans Olov ^b,c   Weiderpass, Elisabete ^b,d,e,f  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; ACRYLAMIDE;

CANCER; COHORT ANALYSIS; HEALTH RISK; HORMONE; LIFESTYLE; MORTALITY; PUBLIC HEALTH; WOMENS HEALTH; YOUNG POPULATION;

ADULT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIETARY INTAKE; EDUCATIONAL STATUS; FEMALE; HUMAN; LIFESTYLE; MALIGNANT NEOPLASM; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; REVIEW; SMOKING; SUN EXPOSURE; ULTRAVIOLET RADIATION; WOMEN'S HEALTH; CEREBROVASCULAR ACCIDENT; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; SWEDEN;

NORWAY; SWEDEN;

ACRYLAMIDE; ADULT; CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; STROKE; SWEDEN; WOMEN'S HEALTH;

EID: 85053263059     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv089     Document Type: Review

References (56)

1. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983;2:926–30.
2. Meirik O, Lund E, Adami HO, Bergstrom R, Christoffersen T, Bergsjo P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet 1986;2:650–54.
3. Meirik O, Lund E, Adami HO, Bergstrom R, Christoffersen T, Bergsjo P. Oral contraceptives and breast cancer. Lancet 1986;2: 1272–73.
4. Shapiro S. Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol 2000;151:939–45.
5. Skegg DC. Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1988;127:205–12.
6. Lund E, Dumeaux V, Braaten T et al. Cohort profile: The Norwegian Women and Cancer Study—NOWAC—Kvinner og kreft. Int J Epidemiol 2008;37:36–41.
7. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital and health statistics Series 2, Data Evaluation and Methods Research 1980;84:1–59.
8. Centralbyrån S. Population Statistics 2015. http://www.scb.se/en_/Finding-statistics/Statistics-by-subject-area/Population/ Population-composition/Population-statistics/ (23 May 2015, date last accessed).
9. Socialstyrelsen. Dödsorsaksregisteret 2015 [The National Board of Health and Welfare. Cause of Death Registry]: http://www.socialstyrelsen.se/register/dodsorsaksregistret (23 May 2015, date last accessed).
10. Socialstyrelsen. Swedish Cancer Registry 2015. http://www.socialstyrelsen.se/register/halsodataregister/cancerregistret/ inenglish (23 May 2015, date last accessed).
11. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
12. Socialstyrelsen. Patientregistret 2015 [The National Board of Health and Welfare. The National Patient Register.] http://www.socialstyrelsen.se/register/halsodataregister/patientregistret (23 May 2015, date last accessed).
13. Ludvigsson JF, Andersson E, Ekbom A et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
14. Wettermark B, Hammar N, Fored CM et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35.
15. Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women’s Lifestyle and Health Cohort Study. Cancer EpidemiolBiomarkers Prev 2002;11:1375–81.
16. Kumle M, Weiderpass E, Braaten T, et al. Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women’s Lifestyle and Health Cohort Study. Br J Cancer 2004; 90:91386–91.
17. Margolis KL, Adami HO, Luo J, Ye W, Weiderpass E. A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women. Fertil Steril 2007;88:310–16.
18. Yang L, Kuper H, Sandin S et al. Reproductive history, oral contraceptive use, and the risk of ischemic and hemorrhagic stoke in a cohort study of middle-aged Swedish women. Stroke;2009;40:1050–58.
19. Lagiou P, Trichopoulos D, Sandin S et al. Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr 2006;96:384–92.
20. Lagiou P, Sandin S, Weiderpass E et al. Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med 2007;261:366–74.
21. Couto E, Sandin S, Lof M, Ursin G, Adami HO, Weiderpass E. Mediterranean dietary pattern and risk of breast cancer. PLoS One 2013;8:e55374.
22. Lagiou P, Sandin S, Lof M, Trichopoulos D, Adami HO, Weiderpass E. Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ 2012;344:e4026.
23. Roswall N, Sandin S, Löf M et al. Adherence to the healthy Nordic food index and total and cause-specific mortality among Swedish women – a cohort study. Eur J Epidemiol 2015. doi: 10.1007/s10654-015-0021-x.
24. Roswall N, Eriksson U, Sandin S et al. Adherence to the healthy Nordic Food Index, dietary composition and lifestyle among Swedish women. Food Nutr Res 2015, Mar 11. doi: 10.3402/ fnr.v59.26336.
25. Roswall N, Li Y, Kyro C et al. No association between adherence to a healthy nordic food index and colorectal cancer: Results from a Swedish Cohort Study. Cancer Epidemiol Biomarkers Prev 2015;24:755–57.
26. Li Y, Roswall N, Sandin S, Strom P, Adami HO, Weiderpass E. Adherence to a healthy Nordic food index and breast cancer risk: results from a Swedish cohort study. Cancer Causes Control 2015, Mar 18. PMID: 25783459. [Epub ahead of print.]
27. Mucci LA, Sandin S, Balter K, Adami HO, Magnusson C, Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. JAMA 2005;293:1326–27.
28. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 2008;138:938–45.
29. Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E. Dietary phytoestrogens and the risk of ovarian cancer in the women’s lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 2011;20:308–17.
30. Lof M, Sandin S, Lagiou P et al. Dietary fat and breast cancer risk in the Swedish women’s lifestyle and health cohort. Br J Cancer 2007;97:1570–76.
31. Hedelin M, Lof M, Olsson M et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population. BMC Psychiatry 2010;10:38.
32. Lof M, Sandin S, Lagiou P, Trichopoulos D, Adami HO, Weiderpass E. Fruit and vegetable intake and risk of cancer in the Swedish women’s lifestyle and health cohort. Cancer Causes Control 2011;22:283–89.
33. Weiderpass E, Sandin S, Lof M et al. Endometrial cancer in relation to coffee, tea, and caffeine consumption: a prospective cohort study among middle-aged women in Sweden. Nutr Cancer 2014;66:1132–43.
34. Administration SNF. Acrylamide in Summary 2013. http://www.livsmedelsverket.se/en/food-and-content/oonskade-amnen/akrylamid/ (23 May 2015, date last accessed).
35. Veierod MB, Weiderpass E, Thorn M et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003;95:1530–38.
36. Veierod MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev 2010;19:111–20.
37. Veierod MB, Couto E, Lund E, Adami HO, Weiderpass E. Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin. Int J Cancer 2014;135: 413–22.
38. Titus-Ernstoff L, Mansson-Brahme E, Thorn M et al. Factors associated with atypical nevi: a population-based study. Cancer Epidemiol Biomarkers Prev 1998;7:207–10.
39. Titus-Ernstoff L, Thorn M, Tosteson TD et al. The accuracy of skin self-examination for atypical nevi. Epidemiology 1996;7: 619–23.
40. Kuper H, Yang L, Sandin S, Lof M, Adami HO, Weiderpass E. Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev 2009;18:2558–61.
41. Veierod MB, Smedby KE, Lund E, Adami HO, Weiderpass E. Pigmentary characteristics, UV radiation exposure, and risk of non-Hodgkin lymphoma: a prospective study among Scandinavian women. Cancer Epidemiol Biomarkers Prev 2010; 19:1569–76.
42. Yang L, Veierod MB, Lof M, Sandin S, Adami HO, Weiderpass E. Prospective study of UV exposure and cancer incidence among Swedish women. Cancer Epidemiol Biomarkers Prev 2011;20: 1358–67.
43. Yang L, Lof M, Veierod MB, Sandin S, Adami HO, Weiderpass E. Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev 2011;20:683–90.
44. Weiderpass E, Braaten T, Magnusson C et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13:1121–27.
45. Lof M, Sandin S, Hilakivi-Clarke L, Weiderpass E. Birth weight in relation to endometrial and breast cancer risks in Swedish women. Br J Cancer 2007;96:134–36.
46. Hjartaker A, Adami HO, Lund E, Weiderpass E. Body mass index and mortality in a prospectively studied cohort of Scandinavian women: the women’s lifestyle and health cohort study. Eur J Epidemiol 2005;20:747–54.
47. Lu M, Ye W, Adami HO, Weiderpass E. Prospective study of body size and risk for stroke amongst women below age 60. J Intern Med 2006;260:442–50.
48. Yang L, Kuper H, Weiderpass E. Anthropometric characteristics as predictors of coronary heart disease in women. J Intern Med 2008;264:39–49.
49. Gram IT, Braaten T, Terry PD et al. Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 2005;14:61–66.
50. Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E. Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 2008;122:647–52.
51. Gram IT, Sandin S, Braaten T, Lund E, Weiderpass E. The hazards of death by smoking in middle-aged women. Eur J Epidemiol 2013;28:799–806.
52. Lu M, Ye W, Adami HO, Weiderpass E. Stroke incidence in women under 60 years of age related to alcohol intake and smoking habit. Cerebrovasc Dis 2008;25:517–25.
53. Margolis KL, Mucci L, Braaten T et al. Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women’s Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev 2005;14:27–32.
54. Trolle-Lagerros Y, Mucci LA, Kumle M et al. Physical activity as a determinant of mortality in women. Epidemiology 2005;16:780–85.
55. Weiderpass E, Margolis KL, Sandin S et al. Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 2006;118:3153–60.
56. Khani BR, Ye W, Terry P, Wolk A. Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr 2004; 134:1541–45.